Speech-Language Pathologists in Martinsville, IL Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Mrs. Leslie Hearn, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 Kendall Street, Martinsville, IL 62442 Phone: 217-382-4116 |
News Archive
New study emphasizes the importance of metabolomics to the advent of personalized medicine
International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.
Researchers develop new tool for global leaders to better control cancer
With the number of global cancer cases expected to increase by more than 50 percent by 2030, researchers around the globe have collaborated to create a new tool for global leaders to determine what actions they must take to better control cancer.
Aria's non-invasive test more effective in detecting Trisomy 18 & 21
Aria Diagnostics, a molecular diagnostics company, today announced publication of data supporting a directed, non-invasive approach to cell-free DNA (cfDNA) analysis in maternal blood for evaluation of two common fetal trisomies linked to genetic disorders.
Wall Street Journal examines railway hospital in India
The Wall Street Journal examines Lifeline Express, "the world's first hospital on rails," which is run by Impact India, a group that "initially focused on immunization and prevention of diseases such as polio and malaria." Its success has spread to China and Zimbabwe, where three Lifeline Express trains are operated, and to "hospital river boats based on the India model have been set up to tend to patients in Bangladesh and Cambodia." It has also been used as a model for other health projects in India, according to the newspaper.
MMRF awards $3 million under 2010 Biotech Investment Awards program
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
› Verified 6 days ago